Just to take an example of neonatal mortality, Darmstadt et al. [ 1] showed that when community-based antenatal healthcare at health facilities is used in ideal conditions and in a population with a ANC coverage of 99%, and when this healthcare is coupled with skilled assistance at delivery and postnatal care covering 90% of the population, it is possible to reduce neonatal mortality by over 70%.
All examples of audified neonatal EEG used in the survey can be found online, http://rennes.ucc.ie/~andreyt/visual/. Neither neonatal clinicians nor other surveyed users had any experience in listening to audified EEG (some have 'listened' to old paper-based EEG machines).
Initially a review of all district-level data is performed, for example number of neonatal tetanus cases and vaccination coverage.
You use the example of a neonatal nurse in California, irate that the state passed legislation mandating that hospitals lock up certain drugs that had always been readily available to the nursing staff.
In addition, optimal conditions to ensure reliable human T and B cell engraftment will likely involve for example the use of neonatal rather than adult mice for engraftment and transgenic expression of select cytokines.
In Sub-Saharan Africa, for example, the proportion of neonatal deaths among under five deaths increased from 37% in 1990 to 40% in 2010 [ 2, 3].
For example, the risk of neonatal death is higher in rural (55 per 1000 live births) compared to urban areas (48 per 1000 live births) [ 6].
One example of direct evidence implicating the role of ANCA comes from a case report of neonatal microscopic polyangiitis secondary to the transplacental transfer of MPO-ANCA [ 24].
For example, blue light treatment of neonatal jaundice1 and white and blue light treatments of seasonal affective disorder and depression2,3,4,5,6,7 are established medical applications.
Consider, for example, recent clinical trials of neonatal ECMO in the USA and the UK.
